China Intelligent Health (Stock Code: 00348) has issued an announcement indicating a significant improvement in its financial performance. The group forecasts an attributable loss to the company's owners of approximately HKD 1.8 million to HKD 3.4 million for the fiscal year ending December 31, 2025. This represents a substantial decrease of about 92% to 96% compared to the attributable loss of roughly HKD 40 million recorded in the previous fiscal year ended December 31, 2024.

According to the announcement, the expected sharp reduction in the loss attributable to owners is primarily due to two key factors. Firstly, the fiscal year 2025 includes an unrealized fair value gain of approximately HKD 25 million on financial assets measured at fair value through profit or loss. This contrasts with an unrealized fair value loss of about HKD 4 million in the 2024 fiscal year. Secondly, a reversal of impairment losses totaling approximately HKD 4 million was recognized in fiscal year 2025 under the expected credit loss model for the group's loan receivables, trade receivables, and other receivables. In comparison, impairment losses of about HKD 2 million were recorded in the 2024 fiscal year.